AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MEMPHASYS LIMITED. Capital/Financing Update 2014

Dec 1, 2014

65314_rns_2014-12-01_af5c4a64-6af6-4571-8ff1-228e6cc7d99a.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [196 x 96] intentionally omitted <==

ASX Release

SALE OF MINOMIC SHARES

Sydney, Australia, 2 December 2014

Sale of Shares in Minomic International Ltd

NuSep Holdings Limited (ASX:NSP) wishes to advise that its wholly owned subsidiary, NuSep Pty Ltd, has sold its equity holding in the biotechnology company, Minomic International Ltd. Net proceeds received from the sale of shares were $377,945.

Executive Chairman Alison Coutts stated, “In line with the company’s strategy to focus our efforts on our core business of SpermSep , we have finalised the sale of shares in Minomic. The proceeds from the sale will assist NuSep to undertake human in vitro clinical trials of the SpermSep technology in leading Australian IVF centres and will also enable us to commence a bovine IVF study in Germany with our partner MiniTϋb GmbH. These studies will further validate the commercial advantages of the SpermSep technology for selecting sperm over current practice.

“The sale has been off the back of the recent announcement of the Heads of Agreement with MiniTϋb GmbH, a global leader in servicing the animal reproduction market. This agreement will allow us to work together to build the international sales of SpermSep sperm selection devices and consumables”, Alison Coutts said.

For further information please contact:

Alison Coutts Executive Chairman +61 2 8415 7300 [email protected]